publication venue for
- OFF-THE-SHELF CAR T CELL IMMUNOTHERAPY FOR GLIOBLASTOMA 2023
- DUOC-01, a cord blood derived cell therapy product, ameliorates experimental autoimmune encephalomyelitis, a murine model for multiple sclerosis 2020
- Non-toxic cross-reactivity with healthy tissues supports in vivo expansion and therapeutic efficacy of T cells engineered with synthetic antigen receptors 2020
- Development of a CD19-TAC therapy in preparation of human trials 2019
- BCMA-specific TAC receptor-engineered T cells for multiple myeloma 2018
- New neuronal lineage tumor antigen and therapeutic targeting thereof 2018
- Optimizing the culture process of engineered t cells to favor long-term efficacy following adoptive immunotherapy 2018
- T cells engineered with T-cell antigen coupler (TAC) receptors display robust efficacy against solid and liquid tumor xenografts in the absence of any toxicity 2018
- UMBILICAL CORD TISSUE DERIVED MESENCHYMAL STROMAL CELLS INHIBIT LYSOPHOSPHATIDYLCHOLINE MEDIATED ACTIVATION OF MICROGLIA IN ORGANOTYPIC CEREBELLAR CULTURES 2017
- Phase II Clinical Trial of Allodepleted T Cell Immunotherapy (ATIR101) Post-Transplant Results in Decreased Transplant-Related Mortality and Improved Survival in Acute Leukemia Patients Undergoing T-Depleted Haploidentical Stem Cell Transplantation 2016
- SELECTIVE DEPLETION OF ALLOREACTIVE T-CELLS WHILE RETAINING VIRUS-SPECIFIC AND MEMORY T-CELLS FROM HAPLOIDENTICAL DONOR LYMPHOCYTES 2016
- Immunotherapy with donor lymphocytes depleted of anti-host reactive cells results in safe and efficacious haploidentical HSCT: interim results from a phase II trial in patients with hematologic malignancies 2014
- Vaccination with autologous dendritic cells pulsed with a MUC1 glycopeptide: a phase I/II study in castrate resistant non-metastatic prostate cancer patients 2013
- Constitutive expression of interleukin-27 diminishes proinflammatory cytokine production without impairing effector function of engineered T cells. 25:913-919. 2023
- T-cell engineered with a fully humanized B-cell maturation antigen-specific T-cell antigen coupler receptor effectively target multiple myeloma. 25:490-501. 2023
- Understanding potential barriers and enablers to a perioperative early phase cell therapy trial. 24:629-638. 2022
- Development of a B-cell maturation antigen-specific T-cell antigen coupler receptor for multiple myeloma. 23:820-832. 2021
- Cellular magnetic resonance imaging of monocyte-derived dendritic cell migration from healthy donors and cancer patients as assessed in a scid mouse model. 13:1234-1248. 2011